Anlon Healthcare develops two new anti-malarial products

20 Sep 2025 Evaluate

Anlon Healthcare has successfully developed two new anti-malarial products, Artemether and Lumefantrine. The company is expected to launch both products by November 2025. This development is in line with its strategy to expand the product portfolio and cater to the evolving needs of its clientele.

Anlon Healthcare is a chemical manufacturing company engaged in manufacturing of pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs), which are supplied to customers both in India and international markets.


Anlon Healthcare Share Price

141.30 -2.55 (-1.77%)
11-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.90
Dr. Reddys Lab 1272.95
Cipla 1512.10
Zydus Lifesciences 922.45
Lupin 2080.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×